BackBoundless Bio Overview

Boundless Bio Total Liabilities

Latest total liabilities for BOLD: $7.8M.

Get informed when a big investor buys or sells

+ Follow
Total Liabilities
$7.77M
↓ 86.31% YoYΔ $-48.99M vs prior year quarter

Peer trimmed avg / median

Loading

Boundless Bio Total Liabilities History

Loading

Boundless Bio vs. peers: Total Liabilities Comparison

Loading

Boundless Bio Total Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Boundless Bio (BOLD) FAQ

As of the most recent data (June 2026), BOLD shows a total liabilities of $7.8M. That compares with $57M in the prior-year period — down 86.3% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, BOLD's total liabilities is now $7.8M (was $57M) — a 86.3% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Boundless Bio is outperforming or lagging.

Tracking BOLD's total liabilities over time shows whether Boundless Bio is scaling, shrinking, or reshaping that part of the business. The current reading is $7.8M That compares with $57M in the prior-year period — down 86.3% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this total liabilities page, Stockcircle has Boundless Bio's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect total liabilities (currently $7.8M) with ownership activity and broader fundamentals.